Tranexamic Acid Tablet
Product Images NDC 59651-839

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Tranexamic Acid (NDC 59651-839). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1 (Tranexamic Fig1)

Figure 1 (Tranexamic Fig1)
A line graph comparing mean menstrual blood loss (mL) over various treatment periods for Tranexamic Acid 3900 mg/day and placebo in 3-cycle and 6-cycle studies. The x-axis represents treatment periods from baseline through six cycles; the y-axis shows mean blood loss. The graph illustrates a decrease in blood loss after the first cycle in all groups, with Tranexamic Acid groups showing generally lower levels than placebo over time.*
FDA Label Image

Package Label-principal Display Panel (650 mg (30 Tablets Bottle))

Package Label-principal Display Panel (650 mg (30 Tablets Bottle))
Label for Tranexamic Acid Tablets USP 650 mg, oral tablets by Aurobindo Pharma Limited. The label indicates 30 tablets per package with prescription-only status. It includes dosage instructions, storage conditions, distributor information, and a barcode.*
FDA Label Image

Chemical Structure (Tranexamic Str)

Chemical Structure (Tranexamic Str)
Chemical structure of tranexamic acid showing a hexane ring with an amino group and a carboxylic acid functional group. This structural formula represents the active ingredient tranexamic acid.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.